Journal article · 2022 · Open access

Cancer statistics, 2022

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, Ahmedin Jemal

CA A Cancer Journal for Clinicians, 72(1), 7–33 · Published 1 January 2022 · DOI 10.3322/caac.21708

Open PDFView at the publisherCite this paper

In brief

“Cancer statistics, 2022” is a 2022 journal article by Rebecca L. Siegel and 3 co-authors, published in CA A Cancer Journal for Clinicians. OpenAlex counts 20,967 citations as of 20 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at CA A Cancer Journal for Clinicians.

Citations
20,967
Most cited in
2023 (7,209)
Field-weighted impact
1923.67
References
100
Authors
4

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes. Incidence data (through 2018) were collected by the Surveillance, Epidemiology, and End Results program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2019) were collected by the National Center for Health Statistics. In 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. Incidence during 2014 through 2018 continued a slow increase for female breast cancer (by 0.5% annually) and remained stable for prostate cancer, despite a 4% to 6% annual increase for advanced disease since 2011. Consequently, the proportion of prostate cancer diagnosed at a distant stage increased from 3.9% to 8.2% over the past decade. In contrast, lung cancer incidence continued to decline steeply for advanced disease while rates for localized-stage increased suddenly by 4.5% annually, contributing to gains both in the proportion of localized-stage diagnoses (from 17% in 2004 to 28% in 2018) and 3-year relative survival (from 21% to 31%). Mortality patterns reflect incidence trends, with declines accelerating for lung cancer, slowing for breast cancer, and stabilizing for prostate cancer. In summary, progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment. More targeted cancer control interventions and investment in improved early detection and treatment would facilitate reductions in cancer mortality.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA A Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708

MLA 9

Siegel, Rebecca L., et al. “Cancer statistics, 2022.” CA A Cancer Journal for Clinicians, vol. 72, no. 1, 2022, pp. 7–33. https://doi.org/10.3322/caac.21708.

Chicago

Siegel, Rebecca L., Kimberly D. Miller, Hannah E. Fuchs, and Ahmedin Jemal. 2022. “Cancer statistics, 2022.” CA A Cancer Journal for Clinicians 72 (1): 7–33. https://doi.org/10.3322/caac.21708.

Harvard

Siegel, R. L. et al. (2022) ‘Cancer statistics, 2022’, CA A Cancer Journal for Clinicians, 72(1), pp. 7–33. doi:10.3322/caac.21708.

IEEE

R. L. Siegel, K. D. Miller, H. E. Fuchs, and A. Jemal, “Cancer statistics, 2022,” CA A Cancer Journal for Clinicians, vol. 72, no. 1, pp. 7–33, 2022, doi: 10.3322/caac.21708.

BibTeX

@article{siegel2022cancer,
  title     = {{Cancer statistics, 2022}},
  author    = {Siegel, Rebecca L. and Miller, Kimberly D. and Fuchs, Hannah E. and Jemal, Ahmedin},
  journal   = {CA A Cancer Journal for Clinicians},
  year      = {2022},
  volume    = {72},
  number    = {1},
  pages     = {7--33},
  doi       = {10.3322/caac.21708},
  url       = {https://doi.org/10.3322/caac.21708}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201322
201511
201611
201811
202188
20223,7063706
20237,2097209
20245,2815281
20253,0373037
20261,7061706

Its field-weighted citation impact is 1923.67: it has been cited 1923.67 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening

  • cancer incidence
  • cancer mortality
  • lung cancer
  • breast cancer
  • prostate cancer
  • tumor staging
  • relative survival
  • cancer screening

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA A Cancer Journal for Clinicians, 72(1), 7–33. https://doi.org/10.3322/caac.21708

How many times has this paper been cited?

20,967 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at CA A Cancer Journal for Clinicians: sign in and open the PDF from this page.

Who wrote this paper?

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, Ahmedin Jemal.

What is the DOI of this paper?

10.3322/caac.21708, permanently at https://doi.org/10.3322/caac.21708. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.